AAAAAA

   
Results: 1-25 | 26-50 | 51-58
Results: 1-25/58

Authors: Fiebiger, W Stummvoll, G Weinlander, G Raderer, M
Citation: W. Fiebiger et al., Does pantoprazole alleviate mouth dryness in patients with Sjogren's syndrome?, RHEUMATOLOG, 40(1), 2001, pp. 110-110

Authors: Virgolini, I Traub, T Novotny, C Leimer, M Fuger, B Li, SR Patri, P Pangerl, T Angelberger, P Raderer, M Andreae, F Kurtaran, A Dudczak, R
Citation: I. Virgolini et al., New trends in peptide receptor radioligands, Q J NUCL M, 45(2), 2001, pp. 153-159

Authors: Wenzel, C Dieckmann, K Fiebiger, W Mannhalter, C Chott, A Raderer, M
Citation: C. Wenzel et al., CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour, LEUK LYMPH, 42(4), 2001, pp. 823

Authors: Hejna, M Kostler, WJ Raderer, M Steger, GG Brodowicz, T Scheithauer, W Wiltschke, C Zielinski, CC
Citation: M. Hejna et al., Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial, EUR J CANC, 37(16), 2001, pp. 1994-2002

Authors: Ulrich-Pur, H Kornek, GV Fiebiger, W Gedlicka, C Raderer, M Lenauer, A Depisch, D Lang, F Pidlich, J Scheithauer, W
Citation: H. Ulrich-pur et al., Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy, ANN ONCOL, 12(9), 2001, pp. 1269-1272

Authors: Raderer, M Osterreicher, C Machold, K Formanek, M Fiebiger, W Penz, M Dragosics, B Chott, A
Citation: M. Raderer et al., Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease, ANN ONCOL, 12(7), 2001, pp. 937-939

Authors: Scheithauer, W Kornek, GV Schuell, B Ulrich-Pur, H Penz, M Raderer, M Lang, F Schneeweiss, B Lenauer, A Depisch, D
Citation: W. Scheithauer et al., Second-line treatment with oxaliplatin plus raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy, ANN ONCOL, 12(5), 2001, pp. 709-714

Authors: Penz, M Kornek, GV Raderer, M Ulrich-Pur, H Fiebiger, W Scheithauer, W
Citation: M. Penz et al., Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy, ANN ONCOL, 12(3), 2001, pp. 421-422

Authors: Penz, M Kornek, GV Raderer, M Ulrich-Pur, H Fiebiger, W Lenauer, A Depisch, D Krauss, G Schneeweiss, B Scheithauer, W
Citation: M. Penz et al., Phase II trial of two-weekly gemcitabine in patients with advanced biliarytract cancer, ANN ONCOL, 12(2), 2001, pp. 183-186

Authors: Virgolini, I Patri, P Novotny, C Traub, T Leimer, M Fuger, B Li, SR Angelberger, P Raderer, M Wogritsch, S Kurtaran, A Kletter, K Dudczak, R
Citation: I. Virgolini et al., Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr(3)-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy, ANN ONCOL, 12, 2001, pp. S41-S45

Authors: Stummvoll, GH Aringer, M Machold, KP Smolen, JS Raderer, M
Citation: Gh. Stummvoll et al., Cancer polyarthritis resembling rheumatoid arthritis as a first sign of hidden neoplasms - Report of two cases and review of the literature, SC J RHEUM, 30(1), 2001, pp. 40-44

Authors: Penz, MZ Fiebiger, WCC Valencak, JB Osterreicher, C Ba-Ssalamah, A Formanek, M Brodowicz, T Chott, A Raderer, M
Citation: Mz. Penz et al., Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma ofthe mucosa-associated lymphoid tissue (MALT)-type: A retrospective analysis, ANTICANC R, 21(4B), 2001, pp. 3049-3052

Authors: Hejna, M Hamilton, G Brodowicz, T Haberl, I Fiebiger, WCC Scheithauer, W Virgolini, I Kostler, WJ Oberhuber, G Raderer, M
Citation: M. Hejna et al., Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract, ANTICANC R, 21(2A), 2001, pp. 1183-1187

Authors: Traub, T Petkov, V Ofluoglu, S Pangerl, T Raderer, M Fueger, BJ Schima, W Kurtaran, A Dudczak, R Virgolini, I
Citation: T. Traub et al., In-111-DOTA-lanreotide scintigraphy in patients with tumors of the lung, J NUCL MED, 42(9), 2001, pp. 1309-1315

Authors: Hejna, M Kostler, WJ Tomek, S Fiebiger, WCC Raderer, M Wiltschke, C Zielinski, CC
Citation: M. Hejna et al., Acceptance of medical information and contentment in cancer patients, WIEN KLIN W, 113(9), 2001, pp. 342-347

Authors: Hejna, M Fiebiger, WCC Reiter, WJ Raderer, M
Citation: M. Hejna et al., Spontaneous erections in a patient with erectile dysfunction after palliative chemotherapy for non-small cell lung cancer, UROL INTERN, 67(2), 2001, pp. 163-164

Authors: Petkov, V Ziesche, R Mosgoeller, W Schenk, P Vonbank, K Stiebellehner, L Raderer, M Brunner, C Kneussl, M Block, LH
Citation: V. Petkov et al., Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment, THORAX, 56(9), 2001, pp. 734-736

Authors: Ulrich-Pur, H Kornek, GV Fiebiger, W Schull, B Raderer, M Scheithauer, W
Citation: H. Ulrich-pur et al., Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabine, ONCOL-BASEL, 60(4), 2001, pp. 313-315

Authors: Raderer, M Kurtaran, A Scheithauer, W Fiebiger, W Weinlaender, G Oberhuber, G
Citation: M. Raderer et al., Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid, ONCOL-BASEL, 60(2), 2001, pp. 141-145

Authors: Ulrich-Pur, H Penz, M Fiebiger, WCC Schull, B Kornek, GV Scheithauer, W Raderer, M
Citation: H. Ulrich-pur et al., Oxaliplatin-induced fever and release of IL-6 (vol 59, pg 187, 2000), ONCOL-BASEL, 60(2), 2001, pp. 145-145

Authors: Raderer, M Chott, A
Citation: M. Raderer et A. Chott, MALT lymphomas and Helicobacter pylori? Reply, GUT, 48(2), 2001, pp. 283-283

Authors: Mirzaei, S Schratter-Sehn, AU Knoll, P Gerber, E Kumpan, W Schiessel, R Raderer, M Kohn, H
Citation: S. Mirzaei et al., Therapy management in rectal carcinoma by staging with 18-FDG-PET, CHIRURG, 72(9), 2001, pp. 1058-1061

Authors: Welzel, N Le, T Marculescu, R Mitterbauer, G Chott, A Pott, C Kneba, M Du, MQ Kusec, R Drach, J Raderer, M Mannhalter, C Lechner, K Nadel, B Jaeger, U
Citation: N. Welzel et al., Templated nucleotide addition and immunoglobulin J(H)-gene utilization in t(11;14) junctions: Implications for the mechanism of translocation and theorigin of mantle cell lymphoma, CANCER RES, 61(4), 2001, pp. 1629-1636

Authors: Scheithauer, W Kornek, GV Ulrich-Pur, H Penz, M Raderer, M Salek, T Haider, K Kwasny, W Depisch, D
Citation: W. Scheithauer et al., Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma - Results of a phase I-II trial, CANCER, 91(7), 2001, pp. 1264-1271

Authors: Virgolini, I Traub, T Leimer, M Novotny, C Pangerl, T Ofluoglu, S Halvadjieva, E Smith-Jones, P Flores, J Li, SR Angelberger, P Havlik, E Andreae, F Raderer, M Kurtaran, A Niederle, B Dubczak, R
Citation: I. Virgolini et al., New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy, Q J NUCL M, 44(1), 2000, pp. 50-58
Risultati: 1-25 | 26-50 | 51-58